Skip to content

Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT in Heel Spur With Plantar Fasciitis

Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT in Heel Spur With Plantar Fasciitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06969820
Acronym
HEALSPUR
Enrollment
35
Registered
2025-05-14
Start date
2026-06-01
Completion date
2028-04-30
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcaneal Spur

Brief summary

The clinical picture of calcaneal spur with plantar fasciitis is a debilitating disease that is difficult to treat with conservative and interventional measures. Radiotherapy has shown very good therapeutic results in retrospective data, which need to be clinically confirmed both subjectively and in terms of image morphology in a prospective approach. Primary objective of the study: To demonstrate a clinical benefit of LDRT: improvement of pain, functionality and quality of life after LDRT

Interventions

PROCEDURELow-dose Radiation Therapy (LDRT) using MRI-based imaging techniques

LDRT using MRI-based imaging techniques by developing an MRI imaging protocol, deep learning-based image enhancement and resolution increase.

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 39 years * Typical clinical picture of plantar fasciitis for at least 3 months without associated trauma, other musculoskeletal co-morbidities or degenerative joint disease * Patients with first-time application of LDRT to the affected joint * Willingness to cooperate and accessibility of patients, especially geographical proximity, for treatment and follow-up * Patients for whom LDRT is indicated independently of the study * Karnofsky Index \>70%

Exclusion criteria

* Achillodynia ("dorsal" calcaneal spur) * Previous trauma to the foot (fracture, tendon rupture) * Musculoskeletal comorbidities of the foot * Acute infections/open wounds in the area of the tendon to be examined or other relevant damage to the tendon to be examined * Local steroid injections into the tendon prior to the study * Rheumatic or vascular diseases, lymphedema * Patients with tumors * Individuals of childbearing potential who do not use adequate contraceptive measures consistently during therapy * Persistent drug, medication or alcohol abuse * Patients who have already undergone radiotherapy for the treatment of cancer * Patients with an increased risk of an MRI examination, including the presence of metal implants, pacemakers or claustrophobia

Design outcomes

Primary

MeasureTime frameDescription
Proof of clinical benefit of LDRT using pain scale36 monthsVisual analog scale: pain scale from 0-10 (0..no pain - 10..worst pain)
Proof of clinical benefit of LDRT using QoL36 monthsQoL: SF-8 (Short Form-8 Health Survey), scale from 0-100 (0..worst score - 100..best score)
Proof of clinical benefit of LDRT using Calcaneodynia score36 monthsCalcaneodynia score, scale from 0-100 (0..worst performance - 100..best performance)
Proof of clinical benefit of LDRT using AOFAS Hindfoot Scale36 monthsAOFAS Hindfoot Scale, Score ranges from 0 to 100, with healthy ankles receiving 100 points.
Proof of clinical benefit of LDRT using Roles and Maudsley Scale36 monthsRoles and Maudsley scale is a 4-point subjective assessment used to evaluate patient pain and limitations in daily activities following treatment. It ranges from 1 (excellent result, no symptoms) to 4 (poor result, symptoms identical or worse than before treatment).

Secondary

MeasureTime frame
Proof of an objectifiable clinical benefit of LDRT using MRI-based imaging techniques by developing an MRI imaging protocol36 months
Correlation of subjective pain parameters with laboratory chemical examinations.36 months
Correlation of subjective pain parameters, gait analyses and tendon elasticity with inflammatory components in the patient serum.36 months
Correlation of immune cell subpopulations with disease severity by correlating them with MRI and laboratory findings.36 months

Countries

Germany

Contacts

CONTACTThomas PD. Dr. med. Weissmann, MD
thomas.weissmann@uk-erlangen.de+49913185
CONTACTLisa Dr. rer. nat. Weissmann, PhD
lisa.weissmann@uk-erlangen.de+49913185

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026